secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kaya Holdings, Inc. (KAYS)
CIK:        0001530746
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001903596-24-000286
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kaya Holdings awarded Oregon psilocybin service center license; first guests within 30 days
--------------------------------------------------------------------------------

- Oregon Health Authority licenses KAYS to operate The Sacred Mushroom psilocybin treatment center in Portland.
- Facility in historic Falcon Building spans ~11,000 sq ft with private rooms, activity zones, indoor garden.
- KAYS subsidiary Fifth Dimension Therapeutics will operate center; first guests expected within 30 days.
- CEO Craig Frank: company well positioned to become leader in psychedelic 'delivery of care'.
- Precedence Research: U.S. behavioral health market from $83B (2022) to $136B by 2032.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1530746/000190359624000286/0001903596-24-000286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1530746/000190359624000286/kays_8k.htm
  HTML page:      https://secwatch.observer/filing/0001903596-24-000286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer